When will Sino Biopharmaceutical (1177.HK stock) report earnings?

Sino Biopharmaceutical is scheduled to announce earnings on **19 Mar 2026**. Investors should check the HKSE timetable and company release for the exact Hong Kong local time and monitor guidance comments that could move 1177.HK stock.

What is the current valuation of 1177.HK stock?

At close on 18 Mar 2026 1177.HK stock traded at **HKD 6.25** with a trailing PE of **24.20** and PB of **2.87**, below the Healthcare sector PE average of **30.85**.

What does Meyka AI forecast for 1177.HK stock?

Meyka AI's forecast model projects a 12-month target of **HKD 10.77** for 1177.HK stock, implying about **72.32%** upside from **HKD 6.25**. Forecasts are projections and not guarantees.

What are the main risks to 1177.HK stock ahead of earnings?

Main near-term risks for 1177.HK stock include weaker-than-expected sales, margin pressure from higher R&D, slower operating cash flow, and inventory build that could compress near-term earnings.

HK Stocks

1177.HK stock closes HKD 6.25 on HKSE 18 Mar 2026: earnings due Mar 19

ByDanny Kontos March 18, 2026March 18, 2026

The focus is on 1177.HK stock after Sino Biopharmaceutical Limited closed at HKD 6.25 on the HKSE on 18 Mar 2026 ahead of an earnings release scheduled for 19 Mar 2026. Trading volume reached 49,591,661.00 shares with a one-day gain of 2.63%, reflecting cautious positioning ahead of the report. Investors will watch EPS of 0.25 and a trailing PE of 24.20 for guidance on margins and growth. This earnings spotlight connects the near-term price move to fundamentals and the company’s guidance expectations.